Skip to content
User

Marty Whitman

Third Avenue Management

Third Avenue Management Neuberger Berman High Yield Strategies stake

total: 405

Third Avenue Management NHS trades

Total transactions:
5
New positions:
1
Sold out:
1
Added:
2
Reduced:
1
Held since:
2013 Q3
Held for:
9 quarters
Latest activity:
2015 Q4
According to 2026 Q2 report, Third Avenue Management doesn't hold any Neuberger Berman High Yield Strategies (NHS) shares. To date, the estimated cost basis is nearly $13.27 for "buy" trades and estimated average "sell" price is $10.52. Third Avenue Management first purchased NHS in 2013 Q3, initially acquiring 229,145 shares. Since the initial investment in Neuberger Berman High Yield Strategies (NHS), Third Avenue Management has made 4 more transactions.

When did Third Avenue Management sell Neuberger Berman High Yield Strategies (NHS)?

Third Avenue Management sold off the entire Neuberger Berman High Yield Strategies (NHS) position in 2015 Q4.

When did Third Avenue Management buy Neuberger Berman High Yield Strategies (NHS)?

Third Avenue Management first invested in Neuberger Berman High Yield Strategies (NHS) in 2013 Q3 at the reported quarter-end price of $13.06 per share.

What's the cost basis of Third Avenue Management's NHS stake?

The estimated cost basis for Neuberger Berman High Yield Strategies (NHS) stake is around $13.27 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$13.27
Weighted AVG sell price:
$10.52

Third Avenue Management's historical trades in Neuberger Berman High Yield Strategies

5 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2015 Q4
0.00%
$10.19
-100% (-425,826)
2014 Q4
0.13%
$12.30
-15.62% (-78,800)
2014 Q1
0.13%
$13.62
+40.95% (+146,600)
2013 Q4
0.09%
$13.26
+56.24% (+128,881)
2013 Q3
0.06%
$13.06
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.